Safety and Efficacy of ESWL for Geriatric Patients With Chronic Pancreatitis (ESWL)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03373682 |
|
Recruitment Status : Unknown
Verified December 2017 by Zhaoshen Li, Changhai Hospital.
Recruitment status was: Active, not recruiting
First Posted : December 14, 2017
Last Update Posted : December 14, 2017
|
Sponsor:
Changhai Hospital
Information provided by (Responsible Party):
Zhaoshen Li, Changhai Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Brief Summary:
Pancreatic extracorporeal shock wave lithotripsy (P-ESWL) is recommended as the first-line treatment for pancreatic stones. However, how well P-ESWL performs in geriatric patients remains unclear. The investigators aimed to evaluate the safety and efficacy of P-ESWL for geriatric patients with chronic pancreatitis.
| Condition or disease |
|---|
| Chronic Pancreatitis Geriatric Extracorporeal Shock Wave Lithotripsy |
This prospective observational study was conducted in patients with painful chronic pancreatitis who underwent P-ESWL. Patients aged over 65 years were included in the geriatric group; patients aged under 65 years who underwent P-ESWL in the same period were assigned to the control group. For investigation of long-term follow-up, the geriatric group were matched with patients from the control group in a 1:1 ratio. The primary outcomes were P-ESWL complications and pain relief. The secondary outcomes included: stone clearance, physical and mental health, quality of life score, and body weight.
| Study Type : | Observational |
| Actual Enrollment : | 1404 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | Safety and Efficacy of Extracorporeal Shock Wave Lithotripsy for Geriatric Patients With Chronic Pancreatitis |
| Actual Study Start Date : | January 1, 2011 |
| Actual Primary Completion Date : | April 30, 2016 |
| Estimated Study Completion Date : | April 30, 2018 |
Resource links provided by the National Library of Medicine
MedlinePlus Genetics related topics:
Hereditary pancreatitis
Primary Outcome Measures :
- P-ESWL complications [ Time Frame: April 30, 2016 ]The complications after P-ESWL. Including post-ESWL pancreatitis, bleeding, infection, steinstrasse, and perforation. The degree of these complications will also be measured.
- Pain relief by the end of follow-up period [ Time Frame: April 30, 2018 ]Participants will be followed up annually either by return visit or telephone call. Condition of abdominal pain or acute pancreatitis attack during follow-up will be measured. Pain relief at the end of the follow-up period was classified as complete relief (Izbicki pain score≤10) or partial relief (Izbicki pain score >10 after a decrease of >50%)
Secondary Outcome Measures :
- Stone clearance as assessed by ERCP performed post-ESWL [ Time Frame: April 30, 2016 ]Stone clearance was evaluated at the ERCP performed post-ESWL, with complete clearance defined as clearance of >90% of the main pancreatic duct stone volume, whereas partial clearance was defined as clearance of 50%-90% of the stone volume.
- Physical and mental health assessed by SF-36 questionnaire [ Time Frame: April 30, 2018 ]Physical and mental health after treatment were assessed according to the scores on the SF-36 questionnaire.
- Quality of life score assessed by the patient [ Time Frame: April 30, 2018 ]Quality of life score after treatment were assessed by the patient and ranged from 0 to 100, with higher scores indicating a better quality of life.
- Body weight [ Time Frame: April 30, 2018 ]Body weight after treatment
Information from the National Library of Medicine
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Study Population
Chronic pancreatitis patients with pancreatic stones in China
Criteria
Inclusion Criteria:
- Patients with painful chronic pancreatitis and radiopaque stones of ≥5mm.
Exclusion Criteria:
- Patients with a suspected or established malignant mass or pancreatic ascites, and pregnant patients.
Information from the National Library of Medicine
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03373682
Locations
| China | |
| Changhai Hospital, Second Military Medical University | |
| Shanghai, China, 200433 | |
Sponsors and Collaborators
Changhai Hospital
Publications:
| Responsible Party: | Zhaoshen Li, Director of Gastroenterology Dept., Changhai Hospital |
| ClinicalTrials.gov Identifier: | NCT03373682 |
| Other Study ID Numbers: |
ESWL-01 |
| First Posted: | December 14, 2017 Key Record Dates |
| Last Update Posted: | December 14, 2017 |
| Last Verified: | December 2017 |
Additional relevant MeSH terms:
|
Pancreatitis Pancreatitis, Chronic Pancreatic Diseases Digestive System Diseases |